Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression

被引:11
作者
Chen, YMA [1 ]
Lin, RH
Lee, CM
Fu, CY
Chen, SC
Syu, WJ
机构
[1] Natl Yang Ming Univ, Inst Publ Hlth, Sch Med, Div Prevent Med, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan
[3] Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan
[4] Taipei Venereal Dis Control Inst, Taipei, Taiwan
关键词
D O I
10.1089/088922299311691
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To study the association between anti-Gag and anti-Nef antibody reactivities and their correlations with disease progression, 174 HIV-1/AIDS patients were followed up for 1 year after they received triple therapy. The antibody reactivities were analyzed using a Western blot test with recombinant Gag and Nef proteins. The results showed that decreasing levels of anti-Gag or anti-Nef antibody correlate with disease progression defined by HIV-1 viral loads or T4 cell counts. After receiving triple treatment for 1 year, 8 of 38 (21.1%) Nef antibody-negative patients became positive, while only 9 of 125 (7.2%) Nef antibody-positive persons lost the antibody reactivity (p < 0.01). Therefore, HIV-1 Nef may serve as a clinical marker of disease progression.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 41 条
[1]   NEF FROM PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUPPRESSES SURFACE CD4 EXPRESSION IN HUMAN AND MOUSE T-CELLS [J].
ANDERSON, S ;
SHUGARS, DC ;
SWANSTROM, R ;
GARCIA, JV .
JOURNAL OF VIROLOGY, 1993, 67 (08) :4923-4931
[2]  
ARMITAGE P, 1994, STAT METHODS MED RES, P207
[3]   DYNAMICS OF MOLECULAR-PARAMETERS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY IN-VIVO [J].
BAGNARELLI, P ;
VALENZA, A ;
MENZO, S ;
MANZIN, A ;
SCALISE, G ;
VARALDO, PE ;
CLEMENTI, M .
JOURNAL OF VIROLOGY, 1994, 68 (04) :2495-2502
[4]   CD4 CELL-SURFACE DOWN-REGULATION IN HIV-1 NEF TRANSGENIC MICE IS A CONSEQUENCE OF INTRACELLULAR SEQUESTRATION [J].
BRADY, HJM ;
PENNINGTON, DJ ;
MILES, CG ;
DZIERZAK, EA .
EMBO JOURNAL, 1993, 12 (13) :4923-4932
[5]  
CHEN YMA, 1990, ADV AP BIOT, V7, P239
[6]  
CHEN YMA, 1991, J IMMUNOL, V147, P2368
[7]   ANTIBODY-RESPONSES IN EARLY HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION IN HEMOPHILIACS [J].
CHOU, MJ ;
LEE, TH ;
HATZAKIS, A ;
MANDALAKI, T ;
MCLANE, MF ;
ESSEX, M .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04) :805-811
[8]   OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE [J].
CHOWERS, MY ;
SPINA, CA ;
KWOH, TJ ;
FITCH, NJS ;
RICHMAN, DD ;
GUATELLI, JC .
JOURNAL OF VIROLOGY, 1994, 68 (05) :2906-2914
[9]   INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS [J].
CONNOR, RI ;
MOHRI, H ;
CAO, YZ ;
HO, DD .
JOURNAL OF VIROLOGY, 1993, 67 (04) :1772-1777
[10]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631